Clinical Trial Update: A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial evaluated ospemifene for vulvar and vaginal atrophy in postmenopausal women and has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar and Vaginal Atrophy

Drugs mentioned

• Ospemifene (ospemifene)

Snippet

Sponsor: Shionogi | Conditions: Atrophy, Vaginal Diseases | Phase 3 | Status: COMPLETED | Results posted: 2013-06-28